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of Nottingham published one of the very first 
electronic journals), it seemed clear that re-
searchers would embrace the new technology to 
help them to collaborate and share their results 
more efficiently.  I expected that the whole 
paradigm of publishing would change rapidly, 
and that the peer review and dissemination 
would be covered by research grants and that 
results would be made freely accessible.  This 
is now happening and is called open-access 
publishing.  It is just that the change has taken 
a decade or two longer to actually come about 
than I expected. 
ATG:		What	trends	are	emerging	in	open-
access	journal	publishing?
DK:  Open-access publishing is basically 
a growing subset of STM publishing, so it is 
subject to the same trends.  Researchers are 
being pressurized to publish more and more. 
This leads to a pressure on peer reviewers 
and on Editors, who need to continue to apply 
the same high standards of peer review to an 
increasing number of incoming submissions.  It 
also puts pressure on subscription journals who 
are having to reject papers that they would never 
have done in the past, because of page budgets, 
and these papers are now being channeled to 
open-access journals, which do not have the 
same limits on space.  This has been the moti-
vation for the launch over the last 12 months 
of Scientific Reports from Nature Publishing 
Group, BMJ Open, G3 from the Genetics So-
ciety of America, Open Biology from the Royal 
Society, and many similar journals.
At the same time research budgets in Europe 
and North America are being cut, while those 
in the emerging markets are increasing rapidly 
— with the output of high-quality scientific 
papers from countries such as China, Brazil, 
and India growing extremely rapidly. So the 
demographics of the authors are changing, 
and they have different needs which we need 
to cater for. 
The other major trend is the move towards 
Open Data — to quote a recent blog on our 
site from Alex Wade of Microsoft: “scholarly 
communication can and should evolve from 
static and disparate data and knowledge repre-
sentation, as embodied in today’s typical PDF 
representations of research papers, to a rich 
integrated content which grows and changes 
the more we learn.”  BioMed Central is again 
leading the field in this regard.
ATG:	 	 What	 has	 been	 the	 impact	 of	
Springer’s	 purchase	 of	 BioMed	 Central	 on	
the	 attitudes	 and	 business	 plans	 of	 BioMed	
Central?
DK:  It is the difference between being a 
start-up company owned by an individual and 
being part of a large international business. 
Springer is interested in the long-term future 
of the business so has invested substantially 
in BioMed Central and allowed us to take a 
longer-term strategic outlook.  Springer’s in-
frastructure is really  helping us to  realize our 
potential for growth.  For example, Springer’s 
global network of offices allows us to have staff 
in key locations, such as China and the U.S., as 
well as to continue to develop our  services and 
tools for our library customers, our  editors, so-
cieties, authors, and reviewers whilst managing 
the spectacular growth in submissions.
ATG:		Tell	us	about	SpringerOpen	and	its	
impact	on	BioMed	Central.	 	 Is	 this	a	game	
changer?	
DK:  SpringerOpen completes the open-
access publishing package from Springer, 
giving authors the chance to publish in a 
high-quality, open-access journal, whatever 
their scientific discipline.  It is “powered by” 
BioMed Central — that is, it uses all of our 
systems and processes but also benefits from 
the powerful Springer branding in the areas 
where Springer is a leading force.  Since its 
launch less than a year ago, SpringerOpen 
has announced  nearly 50 titles in mathematics, 
engineering, information sciences, chemistry, 
and other non-biomedical fields, and is prov-




ematically?  How would you define success 
in	this	case?
DK:  According to Wikipedia, “mathemati-
cians formulate new conjectures and resolve the 
truth or falsity of them by proofs which are suffi-
cient to convince others of their validity.”  When 
Vitek Tracz and Matt Cockerill started BioMed 
Central in 2000, they believed that there was a 
new publishing model that could work in journal 
publishing which would allow open access to 
research in a sustainable way.  This has now been 
proven without doubt.  So, yes, OA publishing 




DK:  Well, BioMed Central was only 
launched 11 years ago, and until recently could 
have been designated a small publisher.  Now, 
with nearly 300 staff and publishing 215 jour-
nals, we are probably medium-sized.  So, as far 
as this small publisher is concerned, OA has been 
a good thing!  In business, whatever size business 
you are, you need to be able to meet the needs 
of your customers.  If you do, you thrive.  If not, 
you fail.  The same is true for small publishers.  If 
customers want OA and they are not in a position 
to provide it, they will fail. 
ATG:  To finish on a personal note, tell us 
about	yourself.		What	do	you	do	in	your	spare	
time?		What	do	you	like	to	read?
DK:  I love to spend time with my partner 
and dog walking in the country.  I love to travel 
and am looking forward to my summer holiday 
walking in the hills in Southern Spain.  I love 
to read, listen to music, go to the theatre, and 
eat great food.  
Interview — Deborah Kahn
from page 44
Publishing Director, BioMed Central 
www.biomedcentral.com
Born and lived:  Born in Manchester, lived in Manchester, London, Utrecht, 
Amsterdam and Oxford.
earlY life:  My parents (a Professor of theoretical astrophysics and a Mathemat-
ics teacher) encouraged me to be curious and question everything.  Has got me 
into hot water from time to time.
Professional career and activities:  STM publisher through and through. 
Started In book and journal production, moved into acquisitions and journal man-
agement.  Ten years with the thomson corporation learning to be an electronic 
publisher.  Tried to leave the industry and become a psychotherapist, but STM 
publishing pulled me back, when I found my dream job (this one!). 
in MY sPare tiMe:  If I had some, I would spend more time with my partner 
and dog, play the piano, walk in the mountains, go to the gym, sing in a choir, 
read more books, cook gourmet food.
favorite BooKs:  The Bone People, A Fine Balance, The Blind Assassin.
Pet Peeves:  People who don’t question things.
Most MeMoraBle career acHieveMent:  That’s for others to assess.
Goal i HoPe to acHieve five Years froM noW:  Still to be enjoying my job 
as much as I am now.
HoW/WHere do i see tHe indUstrY in five Years:  I am continually sur-
prised by the glacial speed of change within the academic publishing.  Really 
nothing much has changed in 300 years.  Granted, electronic communications 
make everything happen much faster, and electronic access makes journals 
much more accessible, but the article PDF still looks much like the printed article 
did when journals were invented, the peer-review system functions in much the 
same way, subscription journals still make up 90% of the market.  So much the 
same I imagine.  
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